Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
ABSTRACT Aims This study aimed to evaluate in vitro activity of β-lactam/β-lactamase inhibitor (BL/BLI) combinations, colistin, tigecycline, and eravacycline against carbapenemase producing Enterobacterales (CPE) uropathogens. Methods This cross-sectional study included 162 urine samples from UTI patients. Enterobacterales isolates were identified using the Remel RapID ONE system.
1. Introduction Urinary tract infections (UTIs) are among the most prevalent bacterial infections in communities. UTI and its related complications cause about 150 million deaths annually at the global level [1,2].
Altmetric share Share announcement Help format_quote Cite thumb_up ... Endorse textsms ... Comment Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Visit our dedicated information section to learn more about MDPI.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
